Evidence map›Paper›PMID 35008534›Full record

ArticleInternational journal of molecular sciences2021

Keisuke Hitachi, Yuri Kiyofuji, Masashi Nakatani, Kunihiro Tsuchida

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Keisuke HitachiDivision for Therapies against Intractable Diseases, Institute for Comprehensive Medical Science (ICMS), Fujita Health University, Toyoake 470-1192, Japan.ORCID 0000-0002-7300-5238
Yuri KiyofujiDivision for Therapies against Intractable Diseases, Institute for Comprehensive Medical Science (ICMS), Fujita Health University, Toyoake 470-1192, Japan.
Masashi NakataniFaculty of Rehabilitation and Care, Seijoh University, Tokai 476-8588, Japan.
Kunihiro TsuchidaDivision for Therapies against Intractable Diseases, Institute for Comprehensive Medical Science (ICMS), Fujita Health University, Toyoake 470-1192, Japan.ORCID 0000-0002-3983-5756
Fujita Health University · JPSeijoh University · JP

Funding

Japan Society for the Promotion of Science 19H03427Japan Society for the Promotion of Science 20K07315Mochida Pharmaceutical (Japan) Grant-in-Aid from the Mochida Memorial Foundation for Medical and Pharmaceutical ResearchNCNP Intramural Research Grants (2-5) for Neurological and Psychiatric Disorders
6 · The paper itself

Abstract

RNA-binding proteins (RBPs) regulate cell physiology via the formation of ribonucleic-protein complexes with coding and non-coding RNAs. RBPs have multiple functions in the same cells; however, the precise mechanism through which their pleiotropic functions are determined remains unknown. In this study, we revealed the multiple inhibitory functions of heterogeneous nuclear ribonucleoprotein K (hnRNPK) for myogenic differentiation. We first identified hnRNPK as a lncRNA

Indexed as

AnimalsBase SequenceCell DifferentiationCell LineEndoplasmic ReticulumHeterogeneous-Nuclear Ribonucleoprotein KHumansMiceMuscle DevelopmentMuscle, SkeletalMyoblastsMyogeninRNA-Binding ProteinsRNA, Long NoncodingSignal TransductionTranscription, GeneticHeterogeneous-Nuclear Ribonucleoprotein KMyogeninRNA-Binding ProteinsRNA, Long Noncodingendoplasmic reticulum stressmyogenic differentiationRNA-binding proteintranscriptional regulation

Identifiers

PMID35008534
PMCPMC8744952
OpenAlexW4225571395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.